[Federal Register Volume 85, Number 130 (Tuesday, July 7, 2020)]
[Notices]
[Pages 40667-40668]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-14525]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Notice of Designation of Scarce Materials or Threatened Materials 
Subject to COVID-19 Hoarding Prevention Measures; Change in Information 
Contact, Removal of Chloroquine Phosphate and Hydroxychloroquine HCl; 
Correction

AGENCY: Office of the Secretary (OS), DHHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: This document updates the March 30, 2020, Federal Register 
Notice entitled ``Notice of Designation of Scarce Materials or 
Threatened Materials Subject to COVID-19 Hoarding Prevention 
Measures,'' by replacing the named contact and updating the ``Notice of 
Designation of Scarce Materials or Threatened Materials'' section.

FOR FURTHER INFORMATION CONTACT: Paige Ezernack, Office of the 
Assistant Secretary for Preparedness and Response, Office of Strategy, 
Policy, Planning, and Requirements, Suite

[[Page 40668]]

5440--O'Neill House Office Building, 200 C Street SW, Washington, DC 
20201, (202) 260-0365.

SUPPLEMENTARY INFORMATION:

I. Background

    In FR Doc. 2020-06641 of March 30, 2020 (85 FR 17592-17593), the 
contact for more information is now [email protected]. Chloroquine 
phosphate and hydroxychloroquine HCl are no longer listed as scarce or 
threatened materials following the withdrawal of the FDA emergency use 
authorizations for these drugs on June 15, 2020.

II. Correction of Errors

    In FR Doc. 2020-06641 of March 30, 2020 (85 FR 17592-17593), make 
the following corrections:
    On page 17592, first full column, in FR Doc. 2020-06641, Further 
Information section, change Bryan Shuy: 202-703-8610; 
[email protected] (mail to: [email protected]) to the ASPR DPA 
Office: 202-838-3420; [email protected].
    On page 17593, first column, in FR Doc. 2020-06641, Notice of 
Designation of Scarce Materials or Threatened Materials, remove ``Drug 
product with active ingredient chloroquine phosphate or 
hydroxychloroquine HCl.''

    Dated: June 30, 2020.
Wilma Robinson,
Deputy Executive Secretary, Department of Health and Human Services.
[FR Doc. 2020-14525 Filed 7-6-20; 8:45 am]
BILLING CODE 4150-37-P